Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Lorcaserin for Cocaine Use: The TLC Study

NCT03192995 is registered in ClinicalTrials.gov with Glenn-Milo Santos as lead sponsor.

NCT NCT03192995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03192995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Lorcaserin for Cocaine Use: The TLC Study
Lead sponsor
Glenn-Milo Santos
Phase
Phase 2
Overall status
Terminated
Start date
January 1, 2018
Completion date
June 30, 2020
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine use disorder